PNAS Editor-in-Chief Placed on Leave

In a gender discrmination lawsuit against the Salk Institute, a female scientist alleges that biologist Inder Verma was dismissive of his female colleagues.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, SHINYA SUZUKI Inder Verma, a renowned cancer biologist at the Salk Institute for Biological Studies, has been placed on leave as editor-in-chief of the Proceedings of the National Academy of Sciences (PNAS) as of Monday this week (January 1).

The move is linked to three gender discrimination lawsuits that were filed by Salk professors Vicky Lundblad, Katherine Jones, and Beverly Emerson in July 2017, Verma tells The San Diego Union-Tribune. Emerson told Science last July that the world-leading institute was a “hostile environment in which [the women were] undermined, disrespected, disparaged, and treated unequally.”

In one of the lawsuits, Lundblad alleges that Verma was one of the leaders at Salk who had been dismissive of female scientists, Science reports.

Nobel laureate Elizabeth Blackburn, a molecular biologist who has been the president of Salk since 2015, has said that the allegations are false, according to The San Diego Union-Tribune. However, the lawsuit filed by Emerson alleges that Blackburn was one of Salk’s leaders who had ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies